Literature DB >> 21910699

Long-term efficacy of etanercept for psoriasis in daily practice.

P P M Van Lümig, R J B Driessen, J B M Boezeman, P C M Van De Kerkhof, E M G J De Jong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21910699     DOI： 10.1111/j.1365-2133.2011.10584.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Real-world adherence to topical therapies in patients with moderate acne.

Authors:  Xuân-Lan Lam Hoai; Viviane De Maertelaer; Thierry Simonart
Journal:  JAAD Int       Date:  2021-01-13

2.  Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis.

Authors:  I Y K Iskandar; D M Ashcroft; R B Warren; M Lunt; K McElhone; C H Smith; N J Reynolds; C E M Griffiths
Journal:  Br J Dermatol       Date:  2017-10-19       Impact factor: 9.302

Review 3.  Fumaric acid esters in the management of psoriasis.

Authors:  Deepak Mw Balak
Journal:  Psoriasis (Auckl)       Date:  2015-01-05

4.  Retention and survival rate of etanercept in psoriasis over 15 years and patient outcomes during the COVID-19 pandemic: The real-world experience of a single center.

Authors:  Nahide Onsun; Begüm Güneş; Ayşegül Yabacı
Journal:  Dermatol Ther       Date:  2020-12-11       Impact factor: 3.858
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.